Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE) Taoufik AlsaadiDeeb M. KayedSuhail Al-Rukn GUIDELINES Open access 19 January 2024 Pages: 257 - 281
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives Mark S. FreedmanPatricia K. CoyleAnthony T. Reder REVIEW Open access 11 January 2024 Pages: 283 - 322
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study Taku HatanoRenpei SengokuOsamu Kano ORIGINAL RESEARCH Open access 16 January 2024 Pages: 323 - 338
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study Patricia Pozo-RosichMessoud AshinaBjørn Sperling ORIGINAL RESEARCH Open access 18 January 2024 Pages: 339 - 353
Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia Wenyan WangXiaofeng WangKaoxiang Sun ORIGINAL RESEARCH Open access 20 January 2024 Pages: 355 - 372
Textbook Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage Following Endovascular Treatment Zisheng LiuYuhao TanQiao Zuo ORIGINAL RESEARCH Open access 23 January 2024 Pages: 373 - 387
Conversion to Brivaracetam Monotherapy in Clinical Practice: A Retrospective Study Simona LattanziNicoletta FoschiAngelo Labate ORIGINAL RESEARCH Open access 01 February 2024 Pages: 389 - 398
Clinical and Polysomnographic Characteristics of Adult Patients with Suspected Obstructive Sleep Apnea from Different Sleep Clinics at a Single Tertiary Center Eunmi LeeHyunjo Lee ORIGINAL RESEARCH Open access 03 February 2024 Pages: 399 - 414
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY) Fabrizio VernieriLuigi Francesco IannoneFederico Torelli ORIGINAL RESEARCH Open access 08 February 2024 Pages: 415 - 435
Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study Eric Freire-AlvarezPaola VanniOlga Sánchez-Soliño ORIGINAL RESEARCH Open access 12 February 2024 Pages: 437 - 447
Understanding the Symptoms and Impacts Experienced by People with Relapsing–Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews Amy BarrettOyebimpe Olayinka-AmaoPaul Kamudoni ORIGINAL RESEARCH Open access 12 February 2024 Pages: 449 - 464
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study Taoufik AlsaadiReem SulimanYazan Bader ORIGINAL RESEARCH Open access 15 February 2024 Pages: 465 - 473
Monitoring of Perioperative Microcirculation Dysfunction by Near-Infrared Spectroscopy for Neurological Deterioration and Prognosis of Aneurysmal Subarachnoid Hemorrhage: An Observational, Longitudinal Cohort Study Shunyan YangBinbin TanLihua Wang ORIGINAL RESEARCH Open access 17 February 2024 Pages: 475 - 495
